Robust 2002 sales seen in foreign-invested pharmaceutical firms

Despite initial perspective that the domestic pharmaceutical industry would suffer a serious setback in its projected turnover and growth last year, the majority of foreign-invested pharmaceutical firms fared well in terms of turnover and net income, thanks to their innovative new drugs. Details:

Download: 2002 sales of major foreign-invested pharmaceutical firms